← Eichor
Study identifier: NCT07255248 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Hoffa's Fat Pad Impingement (HFPI)

Condition: Hoffa's Fat Pad Impingement  ·  Sponsor: Boston Children's Hospital

PhasePhase 4
Planned participants62
Who can joinFemale, 12 Years to 18 Years
Healthy volunteersNo

About this study

The aim of the study is to investigate treatment outcomes for refractory anterior knee pain due to Hoffa's Fat Pad Impingement (HFPI) in young female athletes. Specifically, the study team will study pediatric female athletes with HFPI, and treatment outcomes of US-guided Hoffa's Fat Pad (HFP) corticosteroid injection compared to standard care (physical therapy, bracing, no injection) and saline injection. There will be two arms in this study, 1, a corticosteroid injection and physical therapy and 2, physical therapy and a saline injection. The intent of this study is to measure treatment outcomes, and the research team is not looking at the safety and effectiveness of the lidocaine-methylprednisolone mixture.

This description comes directly from the study's public registry record.

Talk to the study team

Olivia Elie, B.S.  ·  781-953-1086  ·  olivia.elie@childrens.harvard.edu

Dai Sugimoto, PhD  ·  dai.sugimoto@childrens.harvard.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Boston Children's HospitalNorwood, Massachusetts, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07255248